Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial-Reference-Cited by-同舟云学术

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Published:2018-03 Issue:3 Volume:18 Page:285-295
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Torres Antoni,Zhong Nanshan,Pachl Jan,Timsit Jean-François,Kollef Marin,Chen Zhangjing,Song Jie,Taylor Dianna,Laud Peter J,Stone Gregory G,Chow Joseph W

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference26 articles.

1. Multistate point-prevalence survey of health care-associated infections;Magill;N Engl J Med,2014

2. Economic impact of ventilator-associated pneumonia in a large matched cohort;Kollef;Infect Control Hosp Epidemiol,2012

3. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society;Kalil;Clin Infect Dis,2016

4. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia;Jones;Clin Infect Dis,2010

5. Antimicrobial resistance in the intensive care unit: a focus on Gram-negative bacterial infections;MacVane;J Intensive Care Med,2016

Cited by 323 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

2. Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?;BMC Infectious Diseases;2024-09-03

3. Visualized and pH-responsive hydrogel antibacterial coating for ventilator-associated pneumonia;Biomedicine & Pharmacotherapy;2024-09

4. Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against Pseudomonas aeruginosa by Inhibiting Drug Efflux;Antibiotics;2024-08-26

5. Ceftazidime-avibactam versus other antimicrobial agents for treatment of Multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis;Infection;2024-08-24